Morinaga&Co (2201) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 net sales rose 5.8% to ¥128,902 million, while operating income fell 10.5% to ¥11,952 million and parent-attributable profit fell 22.9% to ¥8,510 million.
Sales growth reflected Confectionery & Foodstuffs and U.S. strength, including six months of MyMo consolidation; acquisition impacts and higher input, logistics, and U.S. selling costs weighed on earnings.
Financial highlights
Gross profit rose 6.2% to ¥52,989 million; SG&A increased 12.2% to ¥41,037 million.
Ordinary income was ¥11,841 million (-11.9%); parent-attributable profit was ¥8,510 million (-22.9%), with EPS of ¥101.35 versus ¥130.82.
Operating margin was 9.3% versus 11.0% YoY; gross margin was 41.1% versus 41.0%.
Outlook and guidance
FY2027 net sales guidance remains ¥257,000 million; operating income is ¥21,000 million (-6.2%), ordinary income ¥20,500 million, and parent-attributable profit ¥15,200 million.
Profit guidance was reduced by ¥1,800 million for operating income, ¥1,700 million for ordinary income, and ¥1,300 million for parent-attributable profit; sales guidance is unchanged.
H2 forecasts are net sales ¥128,097 million, operating income ¥9,047 million, ordinary income ¥8,658 million, and parent-attributable profit ¥6,689 million.
FY2027 dividends are forecast at ¥70 per share, including a ¥35 year-end dividend; forecasts assume ¥159 per U.S. dollar.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record 9M sales and higher margins lifted full-year forecasts and the dividend.2201
Q3 2024 - Record FY2023 sales and profit growth, with FY2024 growth forecast amid cost headwinds.2201
Q4 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - Record H1 sales and higher FY2025 guidance despite cost-pressured operating income.2201
Q2 2025 - 9M sales grew 7.8%, but raw-material inflation pressured earnings; FY2025 forecasts held.2201
Q3 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - H1 operating income fell 3.7%, but FY2026 operating-income guidance rose to ¥22.3bn.2201
Q2 2026